These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20410523)

  • 1. Systolic heart failure.
    Vitale J; Carbone F
    N Engl J Med; 2010 Apr; 362(16):1545; author reply 1545-6. PubMed ID: 20410523
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug treatment for chronic systolic heart failure.
    Mörike K; Sindermann JR
    Thorac Cardiovasc Surg; 2010 Feb; 58 Suppl 2():S170-2. PubMed ID: 20101534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical practice. Systolic heart failure.
    McMurray JJ
    N Engl J Med; 2010 Jan; 362(3):228-38. PubMed ID: 20089973
    [No Abstract]   [Full Text] [Related]  

  • 4. Systolic heart failure: a prothrombotic state.
    de Peuter OR; Kok WE; Torp-Pedersen C; Büller HR; Kamphuisen PW
    Semin Thromb Hemost; 2009 Jul; 35(5):497-504. PubMed ID: 19739040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
    Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenergic blockers in chronic systolic heart failure secondary to Chagas' disease.
    Dávila DF; Donis JH; Torres A; Gottberg CF; Ramoni-Perazzi P; Arata de Bellabarba G
    Int J Cardiol; 2008 Aug; 128(1):1-4. PubMed ID: 18378338
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure.
    Thornton PL; Ahmed A
    J Am Coll Cardiol; 2004 Apr; 43(7):1333; author reply 1333-4. PubMed ID: 15063454
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta blockers in systolic heart failure.
    Jackowski L; Azam R
    Aust Fam Physician; 2008 Mar; 37(3):137-9. PubMed ID: 18345362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.
    Peters-Klimm F; Müller-Tasch T; Remppis A; Szecsenyi J; Schellberg D
    J Eval Clin Pract; 2008 Oct; 14(5):823-9. PubMed ID: 19018915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary medical management of systolic heart failure.
    Nair AP; Timoh T; Fuster V
    Circ J; 2012; 76(2):268-77. PubMed ID: 22240600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ACE inhibitor and beta blocker are indispensible in heart failure. With adverse effects consider concomitant medication first].
    Neumaier J
    MMW Fortschr Med; 2004 Mar; 146(12):14. PubMed ID: 15357498
    [No Abstract]   [Full Text] [Related]  

  • 12. [Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].
    Belenkov IuN; Mareev VIu; Skvortsov AA
    Ter Arkh; 2008; 80(9):5-12. PubMed ID: 19555028
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of diastolic heart failure.
    le Jemtel TH; Talreja A
    Rev Cardiovasc Med; 2004; 5 Suppl 4():S37-44. PubMed ID: 15627918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trial.
    Zampino M; O'Connor CM; Gattis WA; Adams KF; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S62-6. PubMed ID: 12594456
    [No Abstract]   [Full Text] [Related]  

  • 16. Heart failure: recent advances in prevention and treatment.
    Fonarow GC
    Rev Cardiovasc Med; 2000; 1(1):25-33, 54. PubMed ID: 12457149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first?
    Fang JC
    Circulation; 2005 Oct; 112(16):2380-2. PubMed ID: 16230494
    [No Abstract]   [Full Text] [Related]  

  • 18. Prescription Bias in the Treatment of Chronic Systolic Heart Failure.
    Arfsten H; Goliasch G; Pavo N; Ulmer H; Hülsmann M; Stefenelli T;
    Ann Intern Med; 2020 Jan; 172(1):70-72. PubMed ID: 31569211
    [No Abstract]   [Full Text] [Related]  

  • 19. Heart failure: Part II.
    Wilkes MS; Middlekauff H; Hoffman JR
    West J Med; 1999 Jun; 170(6):339-42. PubMed ID: 10443162
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-blockers in chronic heart failure.
    Gheorghiade M; Colucci WS; Swedberg K
    Circulation; 2003 Apr; 107(12):1570-5. PubMed ID: 12668487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.